BAKER BROS. ADVISORS LP
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,517,709
(6.1%)
New positions
15
Sold out positions
8
Turnover %
5.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KOD | 1,307,732 | 178.8% |
| ACAD | 511,655 | 29.6% |
| ABCL | 420,515 | NEW |
| PRLD | 419,113 | 137.5% |
| ALXN | 366,288 | 36.5% |
| Invitae Corp | 140,553 | 27.4% |
| BMRN | 88,112 | 15.3% |
| Mirati Therapeutics, Inc. | 75,550 | 32.3% |
| RARE | 61,524 | NEW |
| KYMR | 58,169 | 91.9% |
Top Reduces (Value $000, Stocks/ETFs)
| Seagen Inc. | -971,387 | -10.5% |
| ONC | -794,983 | -20.9% |
| MyoKardia, Inc. | -410,264 | -100.0% |
| EXAS | -188,214 | -100.0% |
| INCY | -88,289 | -3.1% |
| IMMUNOMEDICS INC | -20,211 | -100.0% |
| Forma Therapeutics Holdings, Inc. | -17,624 | -20.0% |
| ASMB | -16,015 | -63.2% |
| MDGL | -11,334 | -6.4% |
| Global Blood Therapeutics, Inc. | -10,888 | -21.5% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|